CHRO Chromocell: Narxning prognoz qilingan daromadga nisbati
Komponentlar yetkazib berish barqarorligi va xalqaro sertifikatsiya Chromocell Therapeutics (CHRO) faoliyati uchun juda muhimdir. Forward P/S ko'rsatkichi biznesning kutilayotgan savdo hajmi nisbatidagi bahosini aks ettiradi va hozirda ushbu metrika darajasida. Noyob og'riq qoldiruvchi molekulalar yuqori narx belgilash imkoniyatini yaratadi. Nihoyat, yirik ishlab chiqarish korxonalarining yo'qligi ekologik xavflarni standart kimyoviy chiqindilarni yo'q qilish qoidalarigacha kamaytiradi.
Chromocell (CHRO) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning xususiy kapitalga nisbati Chromocell Therapeutics|CHRO - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Chromocell Therapeutics|CHRO - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Chromocell|CHRO - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Chromocell Therapeutics|Tezkor likvidlik koeffitsiyenti chromocell.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CHRO - Sof foyda|Kutilayotgan foyda Chromocell Therapeutics|CHRO - Kapitalizatsiyaning sof foydaga nisbati|Forvard P/E multiplikatori Chromocell Therapeutics Corporation|CHRO - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Chromocell|CHRO - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Chromocell Therapeutics|CHRO - So'nggi to'rtta chorak uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi chromocell.com|CHRO - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Chromocell Therapeutics
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Chromocell Therapeutics Corp. CHRO
Forward P/S biznesning bozor qiymatini kutilayotgan yillik daromadga nisbatan belgilaydi va bu potentsial savdo o'sishi uchun to'langan premiumni baholash imkonini beradi. Biznesning prognoz qilingan P/S ko'rsatkichini tahlil qilish orqali investor Chromocell Therapeutics (CHRO) kompaniyasining baholanishidagi spekulyativ tabiatni ko'rishi mumkin, chunki tijorat mahsulotlarining yo'qligi va tashqi moliyalashtirishga bog'liqlik ushbu ko'paytiruvchini erta klinik sinovlarning muvaffaqiyatiga bo'lgan bozor ishonchining ko'rsatkichi qiladi.
Raqobatchilar tahlili
Forvard P/S multiplikatori BIIB (Biogen)|Neurocrine (NBIX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RGC - Narxning prognoz qilingan daromadga nisbati|AXSM: Narxning prognoz qilingan daromadga nisbati|ACADIA Pharmaceuticals (ACAD) - Narxning prognoz qilingan daromadga nisbati|XENE (xenon-pharma.com) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori VKTX|SUPN: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CPRX (Catalyst Pharmaceuticals Inc)|Narxning kutilayotgan daromadga nisbati DNLI|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Sotuvga nisbatan forvard narx BHVN|Amylyx Pharmaceuticals, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Trevi Therapeutics Inc|Praxis Medicines (PRAX) - Narxning prognoz qilingan daromadga nisbati|Anavex Life Sciences Corp - Sotuvga nisbatan forvard narx|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Prothena Corporation|Narxning prognoz qilingan daromadga nisbati Alector, Inc. (ALEC)|ANNX: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori OMER (Omeros)|Neurogene Therapeutics (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ACIU: Forvard narx/daromad multiplikatori|VYGR - Forvard P/S multiplikatori|NMRA (Neumora Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|SCLX: Narxning kutilayotgan daromadga nisbati|TVGN (Tevogen Bio Holdings, Inc.) - Forvard P/S multiplikatori|Alpha Cognition Corp (ACOG) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori CGTX|Forvard narx/daromad multiplikatori inhibikase.com IKT|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Assertio Holdings (ASRT)|Coya - Forvard P/S multiplikatori|Vistagen Therapeutics (VTGN) - Forvard narx/daromad multiplikatori|OVID: Forvard P/S multiplikatori|acumenpharm.com - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati CervoMed|ATHE: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Clene Inc. (CLNN)|PEPG - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|RLMD: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Annovis Bio - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience Inc) - Forvard narx/daromad multiplikatori|Klotho Neurosciences (KLTO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati NeuroSense Therapeutics Ltd|RVPH: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati MetaVia Inc (MTVA)|NRXS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori HSDT (Helius Medical Technologies)|PASG - Forvard narx/daromad multiplikatori|Neuphoria - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx NERV (minervaneurosciences.com)|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Addex Therapeutics Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alzamend Neuro Inc.|Bozor kapitallashuvining kelajakdagi daromadga nisbati Cyclerion CYCN|Narxning prognoz qilingan daromadga nisbati Protagenic Therapeutics (PTIX)|Forvard narx/daromad multiplikatori pasitheaclinics.com KTTA|Narxning prognoz qilingan daromadga nisbati Cortigent CRGT|Avenue Therapeutics Inc. (ATXI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Brainstorm Cell Therapeutics, Inc. - Forvard P/S multiplikatori|Cara Therapeutics Inc (CARA) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|Narxning prognoz qilingan daromadga nisbati Longboard Pharmaceuticals, Inc.|Narxning prognoz qilingan daromadga nisbati MRNS|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|Narxning prognoz qilingan daromadga nisbati NRBO (NeuroBo Pharma)|Sage Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx SNPX|TRVN: Forvard narx/daromad multiplikatori|Vigil Neuroscience - Narxning kutilayotgan daromadga nisbati|WENA: Forvard P/S multiplikatori|Cerevel Corp - Sotuvga nisbatan forvard narx
